Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2218713Generated: October 30, 2026

2-oxo-2,3-Dihydrobenzooxazole-5-boronic acid → 5-(2-Chloro-10,11-dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one

https://huagongshe.com/reaction/2218713

Reaction equation

Participants

RoleNameHCIDCharge
Reactant2-oxo-2,3-Dihydrobenzooxazole-5-boronic acidHCID 59770498—
Reactant5-bromomethylene-2-chloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepteneHCID 68886819—
Product5-(2-Chloro-10,11-dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-oneHCID 68891921—

Reaction Steps

Following procedures essentially as described in Example 219 and using 5-bromomethylene-2-chloro-10,11-dihydro-5H-dibenzo[a,d]cycloheptene (200 mg, 0.630 mmol) and 2-oxo-2,3-dihydro-benzooxazole-5-boronic acid (134 mg, 0.750 mmol), provides the title compound. Purify by UV-guided semi-prep reverse-phase HPLC to obtain 14 mg (6%) of the Z-isomer (Example 222(a)) of title compound as a white solid (MS (ES) 391 (M+NH4), 372 (M−H); HPLC shows 94% purity) and 5 mg (2%) of the E-isomer (Example 222(b)) of the title compound as a white solid. MS (ES) 391 (M+NH4), 372 (M−H); HPLC shows 96% purity.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07411072B2
Source datasetuspto-grants-2008_08
ORD IDord-3967fe5e62734996b832484d2f2667ea
Source noteuspto-grants-2008_08